# UNIVERSITY OF MICHIGAN AT ANN ARBOR: Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| Location | ANN ARBOR, MI |
| Project | Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial) |
| Project number | 5U01AR083132-04 |
| Mechanism | U01 |
| Institute | National Institute of Arthritis and Musculoskeletal and Skin Diseases |
| Award | $1,162,079 |
| Awarded | 2026-09-17 |
| Project period | 2023-09-18 to 2028-08-31 |
| UEI | GNJ7BBP73WE9 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11401961). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.